PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for HURA ( TuHURA Biosciences Inc ) from 2050 to Jun 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. TuHURA Biosciences stock (HURA) PE ratio as of Jun 11 2024 is 0. More Details

TuHURA Biosciences Inc (HURA) PE Ratio (TTM) Chart

To

TuHURA Biosciences Inc (HURA) PE Ratio (TTM) Historical Data

Total 0
  • 1
TuHURA Biosciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

TuHURA Biosciences Inc (HURA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

TuHURA Biosciences Inc
NAICS : 541714 SIC : 2833
Compare
Compare
Traded in other countries / regions
IPO Date
2050-12-31
Description
TuHURA Biosciences Inc is a clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies. The company's lead personalized cancer vaccine candidate, IFx-Hu2.0, is designed to prime the activation of the immune system to target and attack tumor cells by making them look like bacteria. Through an intratumoral injection of a gene coding for emm55, an immunogenic bacterial protein that is then expressed on the surface of tumor cells, the immune system is activated, providing a potent, multivalent systemic response against all neoantigens in a patient's tumor.